This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (63) Citing Articles via Google Scholar Google Scholar Articles by Bavry, A. A. Articles by Askari, A. T. Search for Related Content PubMed PubMed Citation Articles by Bavry, A. A. Articles by Askari, A. T.

Benefit of Early Invasive Therapy in Acute Coronary Syndromes

A Meta-Analysis of Contemporary Randomized Clinical Trials

Anthony A. Bavry, MD, MPH^_*, Dharam J. Kumbhani, MD, SM, Andrew N. Rassi, MD, Deepak L. Bhatt, MD^_* and Arman T. Askari, MD^_*,_*

^_* Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio
Department of Internal Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
School of Medicine, Case Western Reserve University, Cleveland, Ohio.

View larger version (9K): [in this window] [in a new window] [Download PPT slide]   Figure 1 Relative risk of all-cause mortality for early invasive therapy compared with conservative therapy at a mean follow-up of 2 years. The results show a long-term survival benefit from early invasive therapy. CI = confidence interval; FRISC-II = Fragmin and Fast Revascularization During Instability in Coronary Disease; ICTUS = Invasive Versus Conservative Treatment in Unstable Coronary Syndromes Investigators; ISAR-COOL = Intracoronary Stenting With Antithrombotic Regimen Cooling Off; RITA-3 = Randomized Intervention Trial of Unstable Angina; RR = relative risk; TIMI-18 = Thrombolysis In Myocardial Infarction-18; TRUCS = Treatment of Refractory Unstable Angina in Geographically Isolated Areas Without Cardiac Surgery; VINO = Value of First Day Coronary Angiography/Angioplasty in Evolving Non–ST-Segment Elevation Myocardial Infarction.

View larger version (9K): [in this window] [in a new window] [Download PPT slide]   Figure 2 Relative risk of all-cause mortality for early invasive therapy compared with conservative therapy as a function of time. The results show a long-term survival benefit from early invasive therapy without an increase in early adverse events.

View larger version (9K): [in this window] [in a new window] [Download PPT slide]   Figure 3 Relative risk of all-cause mortality based on time of angiography and the extent of revascularization. The results show that invasive therapy at a median of 9.3 h does not provide a greater survival advantage compared with angiography at a median of 39.4 h. In contrast, when a large proportion of invasively treated patients relative to conservatively treated patients undergo revascularization by follow-up, there is a strong improvement in late survival.

View larger version (9K): [in this window] [in a new window] [Download PPT slide]   Figure 4 Relative risk of recurrent nonfatal myocardial infarction for early invasive therapy compared with conservative therapy at a mean follow-up of 2 years. The results show a long-term reduction in myocardial infarction from early invasive therapy. Abbreviations as in Figure 1.

View larger version (8K): [in this window] [in a new window] [Download PPT slide]   Figure 5 Relative risk of recurrent unstable angina resulting in rehospitalization for early invasive therapy compared with conservative therapy at a mean follow-up of 13 months. The results show a long-term reduction in recurrent unstable angina from early invasive therapy. Abbreviations as in Figure 1.